Goldwirt, L <br/><br/>
Reply to 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance' by Funck-Brentano et al.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Feb 2016 
 - 363-4 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdv538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Male<br/>Melanoma--blood<br/>Mutation--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Skin Neoplasms--blood<br/>Sulfonamides--administration & dosage